Literature DB >> 31327862

Neonatal Alloimmune Thrombocytopenia: A Report of Four Cases.

Mizuki Uenaka1, Mayumi Morizane1, Kenji Tanimura1, Masashi Deguchi1, Yasuhiko Ebina1, Makoto Hashimoto2,3, Ichiro Morioka4, Hideto Yamada1.   

Abstract

Antibodies against fetal platelet alloantigens in maternal blood cause neonatal alloimmune thrombocytopenia (NAIT). We encountered four newborns with NAIT from three women. A woman carried anti-human platelet antigen (HPA)-1a antibody, and vaginally delivered a newborn who had subarachnoid hemorrhage and platelet transfusions. She delivered the second newborn by a cesarean section who had no symptom. The second woman carried anti-human leukocyte antigen-A2 antibody and vaginally delivered a newborn who had no symptom. The third woman with a history of recurrent pregnancy losses carried anti-HPA-4b antibody, and delivered a newborn by a cesarean section who received platelet transfusions and immunoglobulin infusions. Antiplatelet antibody screening may be helpful in women who have a history of blood transfusion, or previous neonates with thrombocytopenia or intracranial hemorrhage.

Entities:  

Keywords:  Human leukocyte antigen; Human platelet antigen antibody; NAIT; Neonatal alloimmune thrombocytopenia

Mesh:

Substances:

Year:  2019        PMID: 31327862      PMCID: PMC6668651     

Source DB:  PubMed          Journal:  Kobe J Med Sci        ISSN: 0023-2513


  9 in total

Review 1.  HLA antibodies and fetomaternal alloimmune thrombocytopenia: myth or meaningful?

Authors:  E Taaning
Journal:  Transfus Med Rev       Date:  2000-07

2.  Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia?

Authors:  Esa van den Akker; D Oepkes; A Brand; H H H Kanhai
Journal:  BJOG       Date:  2006-07       Impact factor: 6.531

Review 3.  Fetal and neonatal alloimmune thrombocytopenia: harvesting the evidence to develop a clinical approach to management.

Authors:  Amanda Symington; Bosco Paes
Journal:  Am J Perinatol       Date:  2010-08-10       Impact factor: 1.862

Review 4.  Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.

Authors:  Bjørn Skogen; Mette Kjær Killie; Jens Kjeldsen-Kragh; Maria Therese Ahlen; Heidi Tiller; Tor B Stuge; Anne Husebekk
Journal:  Expert Rev Hematol       Date:  2010-10       Impact factor: 2.929

5.  The natural history of maternal immunization against foetal platelet alloantigens.

Authors:  H Ohto; S Miura; H Ariga; T Ishii; K Fujimori; S Morita
Journal:  Transfus Med       Date:  2004-12       Impact factor: 2.019

6.  Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT).

Authors:  Volker Kiefel; Dirk Bassler; Hartmut Kroll; Bosco Paes; Günter Giers; Juliana Ditomasso; Heidemarie Alber; Monika Berns; Bea Wiebe; Ernst-Markus Quenzel; Jochen Hoch; Andreas Greinacher
Journal:  Blood       Date:  2006-01-10       Impact factor: 22.113

Review 7.  Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis.

Authors:  J A Spencer; R F Burrows
Journal:  Aust N Z J Obstet Gynaecol       Date:  2001-02       Impact factor: 2.100

8.  Fetal and neonatal alloimmune thrombocytopenia.

Authors:  J P Espinoza; J Caradeux; Errol R Norwitz; S E Illanes
Journal:  Rev Obstet Gynecol       Date:  2013

Review 9.  Human platelet antigens - 2013.

Authors:  B R Curtis; J G McFarland
Journal:  Vox Sang       Date:  2013-09-16       Impact factor: 2.144

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.